Coinbase Global, Inc. vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Coinbase Global, Inc. trades at $175.14 (market cap $47.08B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.34 (market cap $2.28B). The key difference: Coinbase Global, Inc. is far larger — about 20.6× SELLAS Life Sciences Group Inc. Common Stock's market cap, and SELLAS Life Sciences Group Inc. Common Stock is trading nearer its 52-week high, Coinbase Global, Inc. nearer its low. Which is the better fit depends on your goals.
| COIN | SLS | |
|---|---|---|
Market Cap | $47.08B | $2.28B |
Volume | 7,082,928 | 3,128,960 |
Sector | Financials | Health |
52-Week High | $387.00 | $15.46 |
52-Week Low | $141.09 | $1.39 |
Typical Hold Time | 78 Days | — |
Enterprise Value | $44.73B | $2.15B |
Signals from Pluang's Aura AI — not financial advice
COIN trades at $172.00, down 7.4% over 24 hours, with a bearish technical signal and recent earnings misses. The company reported $7.18B revenue and $1.26B net income for 2025, but profitability metrics like net income margin and ROE remain negative. Recent news highlights CFTC approval for derivatives expansion and a deepened partnership with Citigroup for stablecoin payments, signaling strategic growth initiatives amid volatile crypto market conditions.
The outlook is mixed: analyst consensus is bullish with a $211.55 price target, but risks include earnings volatility, regulatory scrutiny, and dependence on crypto market cycles. The stock offers growth potential through business diversification, yet investors face significant downside from operational and macroeconomic headwinds.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Coinbase Global, Inc. is a regulated cryptocurrency company that provides customers around the world with a platform for buying, selling, transferring, and storing digital assets. The Company offers a variety of products and services that enable individuals, businesses, and developers to participate in the cryptoeconomy.
Read more on COIN →SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →